Implant Sciences Continues to Expand its Growing EU Market Share
WILMINGTON, Mass., Aug. 25, 2015 /PRNewswire/ — Implant Sciences Corporation OTCQB: IMSC, a leading manufacturer of explosives trace detection ETD and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.
With this contract win, international airports in 11 EU countries have selected Implant Sciences’ QS-B220 since late April 2015, with orders totaling up to 883 units to such airports.”When it comes to security, airport operators and security managers are looking for solutions that are easy to own and operate, while providing optimal security for the traveling public. Our systems feature push-button maintenance and an intuitive operating process,” stated Dr. Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing. “The intuitive nature of the QS-B220 allows the security personnel to focus their attention on security, rather than on navigating the interface of the screening equipment. Our low false alarm rate means fewer passengers being unnecessarily inconvenienced which streamlines the checkpoint passenger flow and also provides a superior screening experience for passengers.”